|
|
Volumn 20, Issue 5, 2014, Pages 639-640
|
|
Asymptomatic lung disease caused by Mycobacterium kansasii as an opportunistic infection in a patient treated with natalizumab for relapsing-remitting multiple sclerosis
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZATHIOPRINE;
NATALIZUMAB;
TUBERCULOSTATIC AGENT;
IMMUNOSUPPRESSIVE AGENT;
MONOCLONAL ANTIBODY;
ASTHMA;
ASYMPTOMATIC INFECTION;
ATYPICAL MYCOBACTERIOSIS;
CASE REPORT;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
DRUG WITHDRAWAL;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
LETTER;
LUNG INFECTION;
MULTIPLE SCLEROSIS;
MYCOBACTERIUM KANSASII;
OPPORTUNISTIC INFECTION;
PNEUMOCONIOSIS;
THORAX RADIOGRAPHY;
DIAGNOSTIC PROCEDURE;
LONG TERM CARE;
LUNG LESION;
MYCOBACTERIA GROWTH INDICATOR TUBE TECHNIQUE;
NONHUMAN;
SPUTUM ANALYSIS;
ASYMPTOMATIC DISEASE;
DRUG ADMINISTRATION;
IMMUNOCOMPROMISED PATIENT;
IMMUNOLOGY;
ISOLATION AND PURIFICATION;
MICROBIOLOGY;
MULTIPLE SCLEROSIS, RELAPSING-REMITTING;
MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS;
OPPORTUNISTIC INFECTIONS;
RESPIRATORY TRACT INFECTIONS;
TREATMENT OUTCOME;
ANTIBODIES, MONOCLONAL, HUMANIZED;
ANTITUBERCULAR AGENTS;
ASYMPTOMATIC DISEASES;
DRUG ADMINISTRATION SCHEDULE;
HUMANS;
IMMUNOCOMPROMISED HOST;
IMMUNOSUPPRESSIVE AGENTS;
MULTIPLE SCLEROSIS, RELAPSING-REMITTING;
MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS;
MYCOBACTERIUM KANSASII;
OPPORTUNISTIC INFECTIONS;
RESPIRATORY TRACT INFECTIONS;
TREATMENT OUTCOME;
|
|
EID: 84899083304
PISSN: 13524585
EISSN: 14770970
Source Type: Journal
DOI: 10.1177/1352458513501572 Document Type: Letter |
|
Times cited : (9)
|
|
References (5)
|
